|
2024
|
Invention
|
Tdg inhibitor compound and use thereof. Provided in the present invention is a compound which inh... |
|
|
Invention
|
Drug for treating tumor having tp53 gene mutation. Disclosed in the present invention is a drug f... |
|
|
Invention
|
Prmt5 inhibitor and the use thereof.
Provided is a class of compounds with methyltransferase inh... |
|
2023
|
Invention
|
Methyltransferase inhibitor and use thereof. A class of compounds having methyltransferase inhibi... |
|
|
Invention
|
Prmt5 inhibitors and use thereof. The present invention provides a class of compounds with inhibi... |
|
|
Invention
|
Class of prmt5 inhibitors and use thereof. Provided is a class of compounds with methyltransferas... |
|
|
Invention
|
Salt crystal form and free base crystal form of kinase inhibitor.
A salt crystal form and a free... |
|
|
Invention
|
Salt crystal form and free base crystal form of kinase inhibitor. A salt crystal form and a free ... |
|
2022
|
Invention
|
Arginine methyltransferase inhibitor and use thereof.
Provided are an arginine methyltransferase... |
|
|
Invention
|
Arginine methyltransferase inhibitor and use thereof. Provided are an arginine methyltransferase ... |
|
2021
|
Invention
|
Compound having kinase inhibitory activity.
The present invention provides compounds having kina... |
|
|
Invention
|
Compound having kinase inhibitory activity. The present invention provides a compound having kina... |
